StonvexLoading…
StonvexStonvexStonvexCore line items from TXNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $487.79M | $2.14B | $1.63B | $974.23M |
Operating Income | $77.01M | $441.18M | $347.46M | $144.59M |
Net Income | $8.01M | $169.83M | $175.11M | $38.81M |
EPS (Diluted) | $0.03 | $1.48 | $1.63 | $0.32 |
Total Assets | $12.14B | $12.06B | $11.97B | $11.68B |
Total Liabilities | $8.61B | $8.60B | $8.50B | $8.45B |
Cash & Equivalents | $5.62M | $18.26M | $32.07M | $22.17M |
Free Cash Flow OCF − CapEx | $-159.53M | $-611.43M | $-459.32M | $-464.00M |
Shares Outstanding | 110.71M | 108.92M | 108.92M | 105.38M |